Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Sunway Berhad (5211.KL)
Subang Jaya, MY
Sunway Berhad, established in 1974 and headquartered in Subang Jaya, Malaysia, operates as an investment holding company with a diverse business portfolio spanning Malaysia, Singapore, China, India, Australia, Indonesia, and other international markets. This subsidiary of Sungei Way Corporation Sdn. Bhd. focuses on several core activities. Its Property Development arm is responsible for conceiving and executing residential and commercial real estate projects. Complementing this, the Property Investment division manages, operates, and leases a broad range of assets, including properties, popular theme parks, hotels, and recreational facilities. This segment also engages in travel agency and time-sharing ventures, and makes strategic investments in real estate investment funds. The Construction segment undertakes extensive building and civil engineering initiatives, alongside providing specialized mechanical, electrical, and piling services. In Trading and Manufacturing, the company produces and distributes a variety of construction and industrial products, essential building materials, and commercial vehicles. Meanwhile, its Quarry operations involve extracting raw materials and manufacturing aggregates, asphalt premix, and ready-mixed concrete. Sunway Berhad's Other Businesses segment encompasses a wide array of activities. It manufactures diverse precast concrete products such as vitrified clay pipes, interlocking pavers, and various types of concrete piles. This segment also offers corporate services including secretarial, share registration, and management support, along with financial services like leases and hire purchases. Additional offerings span interior design, loyalty programs, financial technology solutions (online remittance, venture capital fund management, credit rating), and training. Strategic investments in this segment include online media, electronic parcel locker networks, petrol station operations, and the retail of pharmaceutical products.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3.63% | +0.37% | +2.07% | -7.34% | +0.74% | -3.38% | +15.53% | +248.08% | +252.60% | +330.95% | +503.49% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 4 | 0 |
| Hold | 7 | -2 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Conglomerates: +6.1%+29.1% ★ Q1'26: +396.1% (vs Q1'25)
-
EPS growth Conglomerates: +16.9%+11.8% Q1'26: +5,106.0% (vs Q1'25)
-
FCF margin FCF growth · Conglomerates: +35.9%+18.4% ★ Q1'26: -0.5% (vs Q1'25)
-
EBIT margin Conglomerates: +9.0%+22.1% ★ Q1'26: +82.3% (vs Q1'25)
-
ROIC Conglomerates: +4.7%+7.3% ★ Q1'26: +145.4% (vs Q1'25)
-
Share dilution Conglomerates: +0.0%+0.7% Q1'26: +1.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Conglomerates: 1.28×6.26× Q1'26: 0.23× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 11 Rev. Ana. 12 EPS Ana. |
Dec 2027 12 Rev. Ana. 12 EPS Ana. |
Dec 2028 6 Rev. Ana. 7 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
4.45B
est: 5.08B (-12.4%)
|
4.66B
est: 4.71B (-1.2%)
|
5.38B
est: 5.10B (+5.4%)
|
5.41B
est: 5.45B (-0.8%)
|
4.78B
est: 5.66B (-15.6%)
|
3.83B
est: 4.07B (-5.9%)
|
3.72B
est: 4.39B (-15.2%)
|
5.19B
est: 4.87B (+6.7%)
|
6.14B
est: 5.73B (+7.1%)
|
7.99B
est: 6.80B (+17.5%)
|
10.31B
est: 9.20B (+12.1%)
|
11.09B
9.31B – 12.77B
+20.6% YoY
|
11.94B
9.73B – 16.13B
+7.7% YoY
|
12.84B
10.61B – 16.14B
+7.5% YoY
|
| EBITDA |
272.01M
est: 1.04B (-73.9%)
|
600.23M
est: 966.10M (-37.9%)
|
540.12M
est: 1.05B (-48.4%)
|
702.75M
est: 1.12B (-37.2%)
|
1.35B
est: 1.16B (+16.3%)
|
877.12M
est: 833.97M (+5.2%)
|
793.70M
est: 899.02M (-11.7%)
|
1.21B
est: 998.07M (+20.8%)
|
1.46B
est: 1.17B (+23.9%)
|
904.44M
est: 1.40B (-35.5%)
|
2.43B
est: 1.90B (+28.1%)
|
2.29B
1.92B – 2.64B
+20.6% YoY
|
2.46B
2.01B – 3.33B
+7.7% YoY
|
2.65B
2.19B – 3.33B
+7.5% YoY
|
| EBIT |
1.05B
est: -1.73B (+160.8%)
|
1.02B
est: -1.60B (+163.8%)
|
1.08B
est: -1.74B (+162.2%)
|
1.10B
est: -1.86B (+159.1%)
|
1.03B
est: -1.93B (+153.4%)
|
622.79M
est: -1.38B (+145.0%)
|
565.38M
est: -1.49B (+137.9%)
|
1.11B
est: -1.66B (+166.7%)
|
1.31B
est: -1.95B (+167.4%)
|
760.05M
est: -1.22B (+162.3%)
|
2.28B
est: -1.65B (+238.0%)
|
-1.99B
-2.29B – -1.67B
-20.6% YoY
|
-2.14B
-2.90B – -1.75B
-7.7% YoY
|
-2.31B
-2.90B – -1.91B
-7.5% YoY
|
| Net Income |
732.45M
est: 889.51M (-17.7%)
|
585.88M
est: 777.04M (-24.6%)
|
639.50M
est: 751.85M (-14.9%)
|
658.38M
est: 758.98M (-13.3%)
|
767.25M
est: 896.17M (-14.4%)
|
404.88M
est: 505.53M (-19.9%)
|
347.67M
est: 407.45M (-14.7%)
|
668.61M
est: 714.40M (-6.4%)
|
737.87M
est: 815.02M (-9.5%)
|
1.15B
est: 958.76M (+20.4%)
|
1.30B
est: 1.02B (+27.8%)
|
1.26B
1.11B – 1.46B
+23.7% YoY
|
1.37B
1.12B – 1.55B
+8.3% YoY
|
1.42B
1.10B – 1.90B
+4.2% YoY
|
| SGA |
678.30M
est: 735.05M (-7.7%)
|
823.46M
est: 682.29M (+20.7%)
|
934.11M
est: 738.62M (+26.5%)
|
908.14M
est: 789.74M (+15.0%)
|
944.17M
est: 819.84M (+15.2%)
|
816.58M
est: 588.97M (+38.6%)
|
621.35M
est: 634.91M (-2.1%)
|
654.53M
est: 704.87M (-7.1%)
|
723.73M
est: 829.43M (-12.7%)
|
795.22M
est: 694.35M (+14.5%)
|
—
est: 939.23M (-100.0%)
|
1.13B
950.73M – 1.30B
+20.6% YoY
|
1.22B
993.71M – 1.65B
+7.7% YoY
|
1.31B
1.08B – 1.65B
+7.5% YoY
|
| EPS |
0.17
est: 0.13 (+27.3%)
|
0.12
est: 0.12 (+2.9%)
|
0.13
est: 0.11 (+15.2%)
|
0.14
est: 0.11 (+22.9%)
|
0.15
est: 0.13 (+11.5%)
|
0.07
est: 0.08 (-5.1%)
|
0.06
est: 0.06 (-3.0%)
|
0.12
est: 0.11 (+11.9%)
|
0.12
est: 0.12 (-1.9%)
|
0.17
est: 0.14 (+18.9%)
|
0.19
est: 0.15 (+24.9%)
|
0.19
0.17 – 0.22
+23.7% YoY
|
0.20
0.17 – 0.23
+8.3% YoY
|
0.21
0.16 – 0.28
+4.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-25 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-22 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-21 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-20 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-19 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-18 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-15 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-14 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-13 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-12 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-11 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-08 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-07 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-06 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-05 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-04 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-30 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-29 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-28 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-27 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-15 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Beng Long Lau | President of Sunway Healthcare Group | 6M | male |
| Kok Wing Liew | Group Managing Director of Construction Division | 4M | male |
| Chow Huat Khoo | Managing Director of Hospital & Healthcare Operations of Sunway Healthcare Group | 4M | — |
| Kia Loke Tan | Senior Managing Director to the Chairman's Office | 3M | male |
| Soo Kiong Chung | Managing Director of International Property Development Division | 3M | male |
| Boon Liang Ng | Chief Executive Officer of Building Materials Division | 1M | male |
| Kok Peng Chen | Chief Financial Officer | — | male |
| Lay Ling Teh | Head of Investor Relations | — | female |
| Lee Chin Chin | Company Secretary | — | — |
| Mohammad Anuar bin Taib | President & Non-Independent Executive Director | — | male |
| Shiang Wyne Foo | Chief Human Resources Officer Group Human Resources | — | female |
| Yean Shin Cheah | Deputy President | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 5211.KL
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
